ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML), caused by constitutively active BCR::ABL1 fusion tyrosine kinase, has served as a paradigm for the successful application of molecularly targeted cancer therapy.